Clinical Trial Update: Thymoglobulin Induction Therapy in Kidney Transplantation (6mg/kg vs 4mg/kg) [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update comparing thymoglobulin induction dosing of 6 mg/kg versus 4 mg/kg in kidney transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Failure

Drugs mentioned

• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Asan Medical Center | Conditions: Kidney Failure | Phase 4 | Status: UNKNOWN